Advertisement

Related Videos

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Amit Sanyal, MD: A Clinician’s Perspective

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Advertisement

Advertisement




Jun
11
Today In Oncology
Can AI Provide an Early Alert for Breast Cancer Before Diagnosis
Urologic Surgeon Sworn in as AMA President
Head and Neck Cancer HPV-DeepSeek May Identify Earlier Signs of Postoperative Recurrence
FDA Approves Atezolizumab for Adjuvant Treatment of MRD-Positive MIBC
Perioperative Serplulimab in PD-L1–Positive Gastric Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo